Have a personal or library account? Click to login
Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design Cover

Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design

Open Access
|Apr 2018

Abstract

A reverse-phase HPLC (RP-HPLC) method was developed for strontium ranelate using a full factorial, screening experimental design. The analytical procedure was validated according to international guidelines for linearity, selectivity, sensitivity, accuracy and precision. A separate experimental design was used to demonstrate the robustness of the method. Strontium ranelate was eluted at 4.4 minutes and showed no interference with the excipients used in the formulation, at 321 nm. The method is linear in the range of 20–320 μg mL−1 (R2 = 0.99998). Recovery, tested in the range of 40–120 μg mL−1, was found to be 96.1–102.1 %. Intra-day and intermediate precision RSDs ranged from 1.0–1.4 and 1.2–1.4 %, resp. The limit of detection and limit of quantitation were 0.06 and 0.20 μg mL−1, resp. The proposed technique is fast, cost-effective, reliable and reproducible, and is proposed for the routine analysis of strontium ranelate.

DOI: https://doi.org/10.2478/acph-2018-0019 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 171 - 183
Accepted on: Jan 18, 2018
Published on: Apr 26, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Béla Kovács, Lajos Kristóf Kántor, Mircea Dumitru Croitoru, Éva Katalin Kelemen, Mona Obreja, Előd Ernő Nagy, Blanka Székely-Szentmiklósi, Árpád Gyéresi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.